New treatment option for Pes Planus
Official title Peripheral Magnetic Stimulation of Foot Muscles: Effects on Medial Longitudinal Arch Height and Foot Muscle Strength in Adults With Flat Feet
ClinicalTrials.gov ID: NCT07237321
What this study is testing
- What it's testing
- This study examines the effects of repetitive peripheral magnetic stimulation (rPMS) on foot invertor muscle strength, morphology, and the height of the medial longitudinal arch (MLA) in individuals with flat feet. The rPMS will be applied non-invasively to the extrinsic and intrinsic foot muscles three times per week for twelve weeks.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Age between 18 and 50 years,
- functionally flat feet of participants.
You likely can't join if
- Acute leg injuries,
- diabetes,
- vascular disorders of the lower limbs,
- open wounds or skin lesions on the lower leg or foot,
- participants with metal implants near the stimulation site,
- cardiac pacemaker,
See the full eligibility criteria
- Age between 18 and 50 years,
- functionally flat feet of participants.
- Acute leg injuries,
- diabetes,
- vascular disorders of the lower limbs,
- open wounds or skin lesions on the lower leg or foot,
- participants with metal implants near the stimulation site,
- cardiac pacemaker,
- other orthopedic or neurological conditions that could affect the study results or pose a health risk to the participants.
The study team makes the final eligibility decision.
Where it's taking place
- Ljubljana, Ljubljana, Slovenia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ljubljana, Ljubljana, Slovenia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.